SCHEMBL7703759

SCHEMBL7703759

NC(=O)c1cccc([C@H](Cc2ccccc2)C(=O)CNS(=O)(=O)c2ccccc2)c1NS(=O)(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 2/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
HDAC1 Q13547 1/20 0.39
AURKA O14965 2/20 0.39
RPS6KB1 P23443 2/20 0.39
SLC40A1 Q9NP59 1/20 0.38
KCNA5 P22460 1/20 0.38
KDM4E B2RXH2 1/20 0.37
KEAP1 Q14145 1/20 0.37
HTR6 P50406 1/20 0.37
GAA P10253 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 1/20 0.37
KMT2A Q03164 1/20 0.37
PRMT1 Q99873 1/20 0.37
KAT6A Q92794 1/20 0.36
GBA1 P04062 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12757865 0.68 MMP1 (0.54) CASP1LMNAKDM4EKEAP1GAA
SCHEMBL7704469 0.66 KCNA5 (0.52) CASP1KCNA5KEAP1GAAKAT6A
SCHEMBL7426429 0.66 SIRT2 (0.41) AURKARPS6KB1
SCHEMBL2969958 0.66 MMP1 (0.59) LMNAKDM4EKEAP1GAAALDH1A1
SCHEMBL3416851 0.65 KDM4E (0.60) LMNASLC40A1KCNA5KDM4EGAA
SCHEMBL28930113 0.65 METAP2 (0.62) KDM4EKEAP1GAAALDH1A1TSHR
SCHEMBL20178657 0.63 EPHX1 (0.47) KDM4EALDH1A1MAPTTSHR
SCHEMBL8912407 0.63 MMP2 (0.67) ALDH1A1MAPTKMT2AMMP1
SCHEMBL10788040 0.63 MMP1 (0.59) LMNAKDM4EKEAP1GAAALDH1A1
SCHEMBL359770 0.62 MMP1 (0.79) GAAALDH1A1KMT2AMMP1MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed